Press Release Details

Inspire Medical Systems, Inc. to Present at 2019 Wells Fargo Healthcare Conference

August 21, 2019
Company will also Participate in Investor Meetings at Dougherty & Company 2019 Institutional Investor Conference

MINNEAPOLIS, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the following upcoming investor conferences:

  • Dougherty & Company 2019 Institutional Investor Conference – Participating in investor meetings on Thursday, September 5, at the Millennium Hotel in Minneapolis

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989

INSP Logo.png

Source: Inspire Medical Systems, Inc.